Temasek set to invest USD 130 mln in Niva Bupa Illustrative image – not actual.

Singapore-headquartered investment firm Temasek has emerged as the main contender to buy a minority stake for USD 120-130 million (about Rs 985-Rs 1,070 crore) in health insurance company Niva Bupa Health Insurance, which in majority is owned by Indian private equity firm True North.

The proposed investment round led by Temasek is likely to set the valuation at around Rs 11,000-12,000 crore (USD 1.34 -1.46 billion). With other investors pitching in this round, the total funding is expected to reach up to USD 180-200 million.

True North had acquired a 51 percent stake in Max India in 2019, then known as Max Bupa Health Insurance. It currently owns a 54.51 percent stake in the health insurer, while UK's Bupa holds 44.42 percent through a Singapore investment vehicle, and the remaining stake is held by the company's employees.

Kotak Mahindra Capital has been roped in to facilitate the investment deal.

True North intends to pare its stake in this round, and is seeking a round of primary investment to fund its future growth. This marks the last round of private fundraising for the company.

← All latest storiesBack to top →